Loading...

News

BTL Announces Successful Enforcement of
PRNEWSWIRE January 22,2026 0

Servier delivers solid performance in 20
PRNEWSWIRE January 27,2026 0

Skyhawk Therapeutics Announces Nine Mont
PRNEWSWIRE January 27,2026 0

Indivumed and University of Rochester Me
PRNEWSWIRE December 10,2025 0

Generate:Biomedicines to Initiate Global
PRNEWSWIRE December 01,2025 0

Accord Healthcare Announces Launch of De
PRNEWSWIRE December 02,2025 0

ICP DAS-BMP Attends MOU Signing Ceremony
PRNEWSWIRE November 10,2025 0

Halia Therapeutics to Present Groundbrea
PRNEWSWIRE November 10,2025 0

UPL launches a global campaign '#AFarmer
PRNEWSWIRE November 06,2025 0

Nanoscope Therapeutics Reports Five-Year
PRNEWSWIRE November 04,2025 0

Ofirnoflast (HT-6184) Receives Orphan Dr
PRNEWSWIRE October 23,2025 0

Accord Plasma B.V. Expands Global Plasma
PRNEWSWIRE October 20,2025 0

Benchling Partners with Anthropic to Bui
PRNEWSWIRE October 20,2025 0

NABR Comment on IUCN Determination
PRNEWSWIRE October 14,2025 0

Breakthrough Lectures to Headline the 20
PRNEWSWIRE October 09,2025 0

Halia Therapeutics Strengthens Global Ge
PRNEWSWIRE October 06,2025 0

Fermenta Board Approves Sale of Environm
PRNEWSWIRE September 19,2025 0

SOPHiA GENETICS Expands Collaboration wi
PRNEWSWIRE September 22,2025 0

Fermenta Granted Process Patent for Plan
PRNEWSWIRE September 12,2025 0

Mars Snacking and Unreasonable Group Wel
PRNEWSWIRE September 13,2025 0

Servier acquires potential treatment for
PRNEWSWIRE September 08,2025 0

Recent News

BTL Announces Successful Enforcement of
Servier delivers solid performance in
Skyhawk Therapeutics Announces Nine Month
Indivumed and University of Rochester
Generate:Biomedicines to Initiate Global Phase
Accord Healthcare Announces Launch of
ICP DAS-BMP Attends MOU Signing
Halia Therapeutics to Present Groundbreaking
UPL launches a global campaign
Nanoscope Therapeutics Reports Five-Year Safety
Ofirnoflast (HT-6184) Receives Orphan Drug
Accord Plasma B.V. Expands Global
Benchling Partners with Anthropic to
NABR Comment on IUCN Determination
Breakthrough Lectures to Headline the
Halia Therapeutics Strengthens Global Genomics
Fermenta Board Approves Sale of
SOPHiA GENETICS Expands Collaboration with
Fermenta Granted Process Patent for
Mars Snacking and Unreasonable Group
Servier acquires potential treatment for
Visitor Count 27269